# Exploring Nasal Drop Therapy With Small Extracellular Vesicles for ALS

> **NCT06598202** · PHASE1,PHASE2 · RECRUITING · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 38 (estimated)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** exosomes derived from human umbilical cord blood mesenchymal stem cells for nasal drop
- **DRUG:** a placebo of exosomes derived from human umbilical cord blood mesenchymal stem cells for nasal drop

## Key facts

- **NCT ID:** NCT06598202
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2026-05-30
- **Final completion:** 2026-05-30
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2024-10-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06598202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06598202, "Exploring Nasal Drop Therapy With Small Extracellular Vesicles for ALS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06598202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*